sygnaturediscovery.com

Webseiten-Bericht für sygnaturediscovery.com

Sygnature Discovery - Leading Contract Research Organisation

 Generiert am 06 April 2026 22:57 PM

Aktuelle Statistiken? UPDATE !

Der Wert ist 63/100

SEO Inhalte

Seitentitel

Sygnature Discovery - Leading Contract Research Organisation

Länge : 60

Perfekt, denn Ihr Seitentitel enthält zwischen 10 und 70 Anzahl Zeichen.

Seitenbeschreibung

Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).

Länge : 133

Großartig, denn Ihre Seitenbeschreibung enthält zwischen 70 und 160 Anzahl Zeichen.

Suchbegriffe

Nicht so gut. Wir konnten keine META-Suchbegriffe auf Ihrer Webseite finden. Benutzen Sie dieses kostenlose Werkzeug um META-Suchbegriffe zu erzeugen.

Og META Eigenschaften

Sehr gut, denn diese Webseite nutzt die Vorteile aus den Og Properties.

Eigenschaft Inhalt
locale en_US
type website
title Sygnature Discovery - Leading Contract Research Organisation
description Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
url https://www.sygnaturediscovery.com/
site_name Sygnature
image https://www.sygnaturediscovery.com/wp-content/uploads/2026/02/sygnature-hit-to-lead-team-collaboration-scaled.webp
image:width 2560
image:height 1707
image:type image/webp

Überschriften

H1 H2 H3 H4 H5 H6
1 25 28 137 8 0
  • [H1] Achieving exceptional scientific outcomesthrough connected drug discovery.
  • [H2] World-leading drug discovery solutions, accelerating your compound to the clinic.
  • [H2] We offer deep expertise across the full range of drug discovery solutions.
  • [H2] We deliver world-class scientific expertise and flexible services across every discipline in preclinical discovery.
  • [H2] Integrated Drug Discovery
  • [H2] Computer Aided Drug Design
  • [H2] Protein & Structure
  • [H2] Bioscience
  • [H2] Chemistry
  • [H2] Drug Metabolism and Pharmacokinetics (DMPK)
  • [H2] in vivo Pharmacology
  • [H2] Form and Formulation
  • [H2] We offer specialist expertise across a range of modalities, target classes and therapeutic areas.
  • [H2] Modalities
  • [H2] Target Classes
  • [H2] Therapeutic Areas
  • [H2] World-leading drug discovery
  • [H2] At Sygnature Discovery, we create exceptional scientific outcomes
  • [H2] Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America
  • [H2] Impact that lasts
  • [H2] Our track record
  • [H2] Trusted by customers worldwide
  • [H2] Interested in joining our team?
  • [H2] News & Resources
  • [H2] Ready to start a conversation?
  • [H2] You're in the right place!
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources Overview
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] From Lead to Pre-Candidate Nomination in 18 Months
  • [H3] Sitryx: Empowering New Ideas
  • [H3] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H3] Corcept Therapeutics: Integrated Drug Discovery Collaboration
  • [H3] CellCentric Lead Optimisation Campaign – CCS1477
  • [H3] Fragment-based hit discovery for the epigenetic target, BRD3
  • [H3] Hit Identification to 3 Compounds in the Clinic and 6 Development Candidates
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Computer Aided Drug Design
  • [H4] Bioinformatics
  • [H4] Target Analysis
  • [H4] Virtual Screening
  • [H4] Structure Based Drug Design
  • [H4] Generative AI and Machine Learning
  • [H4] Ligand Based Drug Design
  • [H4] Library Design
  • [H4] ADMET Predictions
  • [H4] Informatics
  • [H4] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H4] Protein Science and Structural Biology
  • [H4] Protein Expression and Purification
  • [H4] Membrane Proteins
  • [H4] Antibodies and Biotherapeutics
  • [H4] Structural Biology
  • [H4] X-Ray Crystallography
  • [H4] cryo-EM
  • [H4] Macromolecular NMR
  • [H4] Protein Characterization
  • [H4] Protein Mass Spectrometry
  • [H4] FIDA
  • [H4] A Comparison of the Structural Techniques used at Sygnature Discovery: X-ray Crystallography, NMR and Cryo-EM
  • [H4] Bioscience
  • [H4] Cell Line Generation
  • [H4] Assay Development
  • [H4] Electrophysiology
  • [H4] High Throughput Screening
  • [H4] Cell Based Assays
  • [H4] Biochemical Assays
  • [H4] Biophysical Assays
  • [H4] Primary Cells and Tissues
  • [H4] Integrating Hit Finding and Direct-to-Biology to Shorten Time to Development Candidate
  • [H4] Chemistry
  • [H4] Medicinal Chemistry
  • [H4] Synthetic Chemistry
  • [H4] Process & Scale-up Chemistry
  • [H4] NMR-Spectroscopy
  • [H4] Separation Sciences
  • [H4] High Throughput Chemistry
  • [H4] Why Early Process Chemistry Matters?
  • [H4] Drug Metabolism and Pharmacokinetics
  • [H4] Physicochemical Profiling
  • [H4] Chemical & Metabolic Stability
  • [H4] Permeability
  • [H4] Tissue Binding
  • [H4] Drug-Drug Interactions
  • [H4] Biotransformation
  • [H4] Analytical Method Development & Bioanalysis
  • [H4] in vivo Pharmacokinetic & Pharmacodynamic Studies
  • [H4] PK & PK/PD Modelling and Simulation
  • [H4] DMPK Consultancy
  • [H4] Dedicated DMPK for Bifunctional Degraders: A Flexible Approach for Flexible Molecules
  • [H4] in vivo Pharmacology
  • [H4] CNS/Pain Models
  • [H4] Metabolic Disease Models
  • [H4] Inflammation & Immunology Models
  • [H4] Oncology Models
  • [H4] Non-Regulatory Toxicology
  • [H4] in vivo Pharmacokinetics
  • [H4] ex vivo Tissue Analysis
  • [H4] Evaluation of Two Novel Compounds Compared to Methadone on Morphine Withdrawal in a Rat Model of Physical dependence
  • [H4] Form & Formulation
  • [H4] Early Clinical Formulation
  • [H4] Solid Form Analysis
  • [H4] Salt and Co-Crystal Screening
  • [H4] Polymorph Screening
  • [H4] Pre-Clinical Formulation
  • [H4] Assessing Lypoprotectant Effect on Particle Size of Liposomal Systems
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Ion Channels
  • [H4] GABAA Receptors
  • [H4] NMDA Receptors
  • [H4] Glycine Receptors
  • [H4] Nicotinic Receptors
  • [H4] TRP Channels
  • [H4] Sodium Channels
  • [H4] Calcium Channels
  • [H4] Potassium Channels
  • [H4] Chloride Channels
  • [H4] TMEM175
  • [H4] Delivering Custom Cell-Based Tools for Drug Discovery
  • [H4] Sygnature Discovery Successfully Provides Clinical Candidate to Corcept Therapeutics
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] Blog
  • [H4] Webinars & Podcasts
  • [H4] Posters
  • [H4] Journal Papers
  • [H4] Technical Notes
  • [H4] Case Studies
  • [H4] eBooks
  • [H4] Protocols
  • [H4] News
  • [H4] Events
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] UK (Nottingham)
  • [H5] Our Office Locations
  • [H5] Drug Discovery
  • [H5] modalities
  • [H5] Target Classes
  • [H5] Scientific solutions
  • [H5] Therapeutic Areas
  • [H5] Website
  • [H5] Resource Hub

Bilder

Es konnten 77 Bilder auf dieser Webseite gefunden werden.

Bei 38 Bilder(n) fehlt ein ALT-Attribut. Fügen Sie ALT-Attribute zu Ihren Bildern, um die Bedeutung der Bilder für Suchmaschinen zugänglich zu machen.

Text/HTML Verhältnis

Anteil : 26%

Ideal! Das Text zu HTML Code Verhältnis dieser Webseite ist zwischen 25 und 70 Prozent.

Flash

Perfekt, denn es wurde kein Flash auf Ihrer Webseite gefunden.

IFrame

Schlecht, denn Sie verwenden IFrames auf Ihrer Webseite, die von Suchmaschinen nicht indexiert werden können.

URL Rewrite

Gut. Ihre Links sind für Suchmaschinen gut lesbar (sprechende Links)!

Underscores in the URLs

Wir haben Unterstriche in Ihren Links entdeckt. Benutzen Sie zur Optimierung besser Bindestriche in Ihren Links.

In-page links

We found a total of 70 links including 4 link(s) to files

Anker Typ Natürlich
Explore the STORM Therapeutics case study intern natürliche Links
Contact intern natürliche Links
Contact us intern natürliche Links
Get in touch intern natürliche Links
What we do intern natürliche Links
Learn more about Drug Discovery intern natürliche Links
Learn more about Scientific Solutions intern natürliche Links
Explore CADD intern natürliche Links
Explore Protein and Structure intern natürliche Links
Explore Bioscience intern natürliche Links
Explore Chemistry intern natürliche Links
Explore DMPK intern natürliche Links
Explore in vivo Pharmacology intern natürliche Links
Explore Form and Formulation intern natürliche Links
Discover our Modalities intern natürliche Links
Learn more about Target Classes intern natürliche Links
Explore our Therapeutic Areas intern natürliche Links
At Sygnature Discovery, we create exceptional scientific outcomes intern natürliche Links
Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America intern natürliche Links
Impact that lasts intern natürliche Links
Learn more intern natürliche Links
Read the case study intern natürliche Links
Read the case study intern natürliche Links
Read the case study intern natürliche Links
Read the case study intern natürliche Links
Read the case study intern natürliche Links
Read the case study intern natürliche Links
View our Careers Page intern natürliche Links
Bringing Connected Drug Discovery Together Under One Name intern natürliche Links
Dr Simon Hirst awarded prestigious honorary Doctorate from the University of Nottingham intern natürliche Links
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment intern natürliche Links
Sygnature Discovery boosts growth of its in vivo Pharmacology business with appointment of new Vice President intern natürliche Links
Sygnature Discovery Appoints New Chief Commercial Officer to Drive Next Phase of Business Growth intern natürliche Links
Sygnature Discovery appoints Rick Davies to spearhead growth as Director of its UK Protein Sciences and Structural Biology business (formerly, Peak Proteins) intern natürliche Links
View all locations intern natürliche Links
Target Identification & Validation intern natürliche Links
Hit Identification intern natürliche Links
Hit-to-Lead intern natürliche Links
Lead Optimization intern natürliche Links
Small Molecules intern natürliche Links
Peptides intern natürliche Links
Targeted Protein Degradation intern natürliche Links
ADCs intern natürliche Links
Biologics intern natürliche Links
Ion channels intern natürliche Links
GPCRs intern natürliche Links
Transporters intern natürliche Links
Oncology intern natürliche Links
Inflammation and Immunology intern natürliche Links
Neuroscience intern natürliche Links
Metabolic Diseases intern natürliche Links
Meet our Team intern natürliche Links
Working with us intern natürliche Links
Environmental, social, governance intern natürliche Links
Blog intern natürliche Links
Webinars & Podcasts intern natürliche Links
Posters intern natürliche Links
Journal Papers intern natürliche Links
Technical Notes intern natürliche Links
eBooks intern natürliche Links
Protocols intern natürliche Links
Case Studies intern natürliche Links
News intern natürliche Links
Events intern natürliche Links
Privacy Policy intern natürliche Links
Cookie Policy intern natürliche Links
Website terms of use intern natürliche Links
Modern Slavery Statement intern natürliche Links
Supplier Code of Conduct intern natürliche Links
Website Design Agency extern natürliche Links

SEO Suchbegriffe

Suchbegriffswolke

integrated from drug target sygnature chemistry expertise solutions design discovery

Keywords Consistency

Suchbegriff Inhalt Seitentitel Suchbegriffe Seitenbeschreibung Überschriften
discovery 91
drug 68
sygnature 33
integrated 26
expertise 25

Benutzerfreundlichkeit

URL

Domain : sygnaturediscovery.com

Länge : 22

Favoriten Icon

Gut. Die Webseite hat ein Favicon.

Druckeigenschaften

Gut. Es konnten druckfreundliche CSS-Angaben gefunden werden.

Sprache

Gut, denn Sie haben in den META-Elementen eine Sprache deklariert: en.

Dublin Core

Diese Webseite nutzt nicht die Vorteile der Dublin Core Elemente.

Dokument

Doctype

HTML 5

Verschlüsselung

Perfekt, denn Ihre Webseite deklariert einen Zeichensatz: UTF-8.

W3C Validität

Fehler : 0

Warnungen : 0

E-Mail Datenschutz

Achtung! Es wurde mindestens eine E-Mail Adresse im Klartext auf Ihrer Webseite gefunden. Benutzen Sie dieses kostenlose Werkzeug um E-Mail Adressen vor SPAM zu schützen.

Veraltetes HTML

Sehr gut! Sie verwenden aktuelle HTML Tags in Ihrem Webseitenquelltext.

Tipps zur Webseitengeschwindigkeit

Sehr gut, denn Ihre Webseite benutzt keine verschachtelten Tabellen.
Schlecht, denn es wurden CSS-Angaben in HTML-Elementen entdeckt. Diese Angaben sollten in ein entsprechendes CSS-Stylesheet verlagert werden.
Nicht so gut, denn Ihre Webseite enthält sehr viele CSS-Dateien (mehr als 4).
Nicht so gut, denn Ihre Webseite enthält viele Javascript-Dateien (mehr als 6).
Gut! Sie nutzen die Vorteile von gzip.

Mobile

Mobile Optimierung

Apple Icon
META Viewport Tag
Flash Inhalt

Optimierung

XML-Sitemap

Perfekt! Ihre Seite hat eine XML-Sitemap.

https://www.sygnaturediscovery.com/sitemap_index.xml

Robots.txt

https://sygnaturediscovery.com/robots.txt

Sehr gut! Ihre Webseite enthält eine robots.txt-Datei.

Analytics

Fehlt

Wir haben nicht ein Analyse-Tool auf dieser Website installiert zu erkennen.

Webanalyse erlaubt die Quantifizierung der Besucherinteraktionen mit Ihrer Seite. Insofern sollte zumindest ein Analysetool installiert werden. Um die Befunde abzusichern, empfiehlt sich das parallele Verwenden eines zweiten Tools.

PageSpeed Insights

Gerät
Kategorien

Free SEO Testing Tool

Free SEO Testing Tool ist ein kostenloses SEO Werkzeug zur Analyse Ihrer Webseite